Ignite Creation Date:
2024-05-05 @ 5:01 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00360477
Status:
COMPLETED
Last Update Posted:
2016-12-13
First Post:
2006-08-03
Brief Title:
FloSeal Tubeless Exit Versus Cope Loop Nephrostomy Versus Fascial Stitch Following Percutaneous Nephrolithotripsy
Sponsor:
University of California Irvine
Organization:
University of California Irvine
Study Overview
Official Title:
Prospective Randomized Trial of Floseal Tubeless Exit vs Cope Loop Nephrostomy vs Fascial Stitch Following Percutaneous Nephrolithotripsy
Status:
COMPLETED
Status Verified Date:
2016-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The patient will be asked to participate in a research project designed to determine the best way to prevent bleeding and promote patient comfort after having kidney stones removed Two standard methods for ending the surgery are being compared to a newer method In one standard method the patient will have a tube draining urine from the kidney after the procedure This tube may also prevent bleeding from the kidney In another standard method the patient will have a tube left internally that drains urine from the kidney to the bladder and a stitch will be used to close the incision and deeper tissues in the back In the third potential option a tube would be left internally to drain urine from the kidney to the patients bladder and the surgical site would be filled with a clot promoting agent FloSeal which is a FDA approved agent specifically formulated to stop bleeding during surgical procedures
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None